Thasneem, K.V. Musaina, et al. “SGLT2 Inhibitors: A Noval Therapuetic Agent in the Treatment of Diabetic Kidney Disease”. Journal of Drug Delivery and Therapeutics, vol. 10, no. 6, Nov. 2020, pp. 203-6, https://doi.org/10.22270/jddt.v10i6.4532.